Embolic Protection Devices

Patient morbidity and mortality due to compromised or impaired cardiovascular health is one of the most significant healthcare segments worldwide, particularly in developed economies. For the millions of patients of cardiovascular disease, peripheral artery disease, and related vascular insufficiency conditions, interventional cardiology is a primary therapeutic avenue for alleviating symptoms and improving quality of life. The number of interventional procedures performed in developed countries has steadily increased over the past 10 years and will continue to grow at a healthy rate. For these patients, the evolving capabilities of embolic protection devices (EPD) have become an essential element in treatment decisions and patient outcomes. Originally focused on CABG procedures, particularly those involving SVG, the use of EPD is spreading to percutaneous interventions in other parts of the vasculature, notably the carotid and femoral arteries and peripheral artery disease in general. Other significant indications for embolic protection include renal artery insufficiency and interventional procedures for cerebrovascular defects.

Publication Date: February 2010

Summary of Contents (See Prospectus for Details)

Executive Summary

Interventional Cardiology Market Dynamics

Cardiovascular Health Demographics

Established Therapeutic Targets

Demand Drivers

Factors Limiting Growth

Competitive Landscape

Interventional Cardiology Demand for Embolic Protection Devices

Balloon Angioplasty

Stenting Procedures

Stent Placement

Stent Retrieval

Saphenous Vein Grafts

Other Important Clinical Applications

Embolic Protection Market Sector Assessments and Forecasts

Coronary Procedures

Carotid/Neurology Procedures

Peripheral Artery Procedures

Embolic Protection Product Segments and Design Factors

Occlusion Devices

Proximal Occlusion

Distal Occlusion

Filter-based Devices

Other Technologies

Commercial Embolic Protection Devices

Development-stage Embolic Protection Devices

Market Factors

Stent Delivery and EPD Bundling

FDA Guidance and Regulatory Climate

Clinical Trial Factors

Patent Life/Life Cycle Issues

Company Profiles

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.